These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gold distribution in whole blood during chrysotherapy. Smith PM; Smith EM; Gottlieb NL J Lab Clin Med; 1973 Dec; 82(6):930-7. PubMed ID: 4202278 [No Abstract] [Full Text] [Related]
5. [Transport and effect of gold in vivo during gold therapy of chronic rheumatoid arthritis]. Yamanaka K; Yamada O; Minoda M; Yamazaki S Rinsho Byori; 1971 Aug; 19():Suppl:198-9. PubMed ID: 5167919 [No Abstract] [Full Text] [Related]
8. Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis. Krusius FE; Markkanen A; Peltola P Ann Rheum Dis; 1970 May; 29(3):232-5. PubMed ID: 5432590 [No Abstract] [Full Text] [Related]
9. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination. van Riel PL; Gribnau FW; van de Putte LB J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion. Gottlieb NL; Smith PM; Smith EM Arthritis Rheum; 1974; 17(2):171-83. PubMed ID: 4814979 [No Abstract] [Full Text] [Related]
11. [Significance of serum gold level determination during chrysotherapy]. Bahous I; Müller W Verh Dtsch Ges Rheumatol; 1976; 4():395-400. PubMed ID: 997815 [No Abstract] [Full Text] [Related]
12. Experience and rationale of monitoring plasma levels of gold in rheumatoid arthritis. Lorber A Agents Actions Suppl; 1981; 8():539-73. PubMed ID: 6781239 [No Abstract] [Full Text] [Related]
15. Gold binding to blood cells and serum proteins during chrysotherapy. van de Stadt RJ; Abbo-Tilstra B Ann Rheum Dis; 1980 Feb; 39(1):31-6. PubMed ID: 6769399 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of gold in rheumatoid arthritis. Gottlieb NL; Gray RG Agents Actions Suppl; 1981; 8():529-38. PubMed ID: 7008561 [No Abstract] [Full Text] [Related]
18. [Can complications with gold therapy be anticipated?]. Králík V Fysiatr Revmatol Vestn; 1968 Apr; 46(2):93-7. PubMed ID: 5690307 [No Abstract] [Full Text] [Related]
19. Proceedings: Factors governing safety and success of gold salt therapy in rheumatoid arthritis (RA). A prospective study. De Bosset P; Bitter T Ann Rheum Dis; 1975 Apr; 34(2):196. PubMed ID: 1137446 [No Abstract] [Full Text] [Related]